Grégory Menchon

685 total citations
11 papers, 424 citations indexed

About

Grégory Menchon is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Grégory Menchon has authored 11 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cell Biology and 3 papers in Organic Chemistry. Recurrent topics in Grégory Menchon's work include Microtubule and mitosis dynamics (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Structure and Dynamics (2 papers). Grégory Menchon is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Structure and Dynamics (2 papers). Grégory Menchon collaborates with scholars based in Switzerland, France and United States. Grégory Menchon's co-authors include A.E. Prota, Michel O. Steinmetz, Luke A. Gilbert, Yuwen Chen, Max A. Horlbeck, Marco Jost, Min Y. Cho, Jonathan S. Weissman, Lenno Krenning and Ankit Rai and has published in prestigious journals such as Nature Communications, Molecular Cell and Scientific Reports.

In The Last Decade

Grégory Menchon

11 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grégory Menchon Switzerland 9 268 158 58 57 30 11 424
Sevil Zencir Türkiye 13 355 1.3× 130 0.8× 89 1.5× 24 0.4× 24 0.8× 32 579
Robert G. Boyle United Kingdom 8 237 0.9× 74 0.5× 55 0.9× 37 0.6× 19 0.6× 8 313
Yusuke Kamada Japan 15 497 1.9× 59 0.4× 125 2.2× 31 0.5× 32 1.1× 23 634
Ehab M. Khalil United States 11 562 2.1× 170 1.1× 92 1.6× 30 0.5× 18 0.6× 13 717
Kia Strömberg Sweden 9 323 1.2× 60 0.4× 96 1.7× 35 0.6× 51 1.7× 10 491
Cuifen Hou United States 13 400 1.5× 76 0.5× 102 1.8× 80 1.4× 41 1.4× 23 586
Barri Wautlet United States 9 191 0.7× 152 1.0× 119 2.1× 22 0.4× 43 1.4× 11 414
Ming Guo China 8 353 1.3× 132 0.8× 134 2.3× 23 0.4× 20 0.7× 14 540
Marcello Tortorici Italy 10 504 1.9× 50 0.3× 26 0.4× 35 0.6× 42 1.4× 10 589
Zhiqiang Dong China 13 394 1.5× 63 0.4× 85 1.5× 67 1.2× 23 0.8× 28 601

Countries citing papers authored by Grégory Menchon

Since Specialization
Citations

This map shows the geographic impact of Grégory Menchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégory Menchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégory Menchon more than expected).

Fields of papers citing papers by Grégory Menchon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégory Menchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégory Menchon. The network helps show where Grégory Menchon may publish in the future.

Co-authorship network of co-authors of Grégory Menchon

This figure shows the co-authorship network connecting the top 25 collaborators of Grégory Menchon. A scholar is included among the top collaborators of Grégory Menchon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégory Menchon. Grégory Menchon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Menchon, Grégory, et al.. (2025). A genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanoma. Molecular Therapy — Nucleic Acids. 36(3). 102577–102577. 1 indexed citations
2.
Menchon, Grégory, Laurent Maveyraud, & Georges Czaplicki. (2023). Molecular Dynamics as a Tool for Virtual Ligand Screening. Methods in molecular biology. 2714. 33–83. 1 indexed citations
3.
Jost, Marco, Yuwen Chen, Luke A. Gilbert, et al.. (2020). Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent. Molecular Cell. 79(1). 191–198.e3. 24 indexed citations
5.
Menchon, Grégory, Laurent Maveyraud, & Georges Czaplicki. (2018). Molecular Dynamics as a Tool for Virtual Ligand Screening. Methods in molecular biology. 1762. 145–178. 16 indexed citations
6.
Menchon, Grégory, A.E. Prota, Daniel Lucena‐Agell, et al.. (2018). A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin. Nature Communications. 9(1). 2106–2106. 45 indexed citations
7.
Jost, Marco, Yuwen Chen, Luke A. Gilbert, et al.. (2017). Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent. Molecular Cell. 68(1). 210–223.e6. 156 indexed citations
8.
Döhle, Wolfgang, Fabrice Jourdan, Grégory Menchon, et al.. (2017). Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure. Journal of Medicinal Chemistry. 61(3). 1031–1044. 111 indexed citations
9.
Field, Jessica J., Benet Pera, Juan Estévez‐Gallego, et al.. (2017). Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites. Journal of Natural Products. 81(3). 494–505. 15 indexed citations
10.
Menchon, Grégory, Michel Baltas, Alain Milon, et al.. (2016). Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV Interface. Scientific Reports. 6(1). 22878–22878. 14 indexed citations
11.
Ceccom, Johnatan, Laura Dugué, Grégory Menchon, et al.. (2014). Anisomycin injection in area CA3 of the hippocampus impairs both short-term and long-term memories of contextual fear. Learning & Memory. 21(6). 311–315. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026